Opposition leader Vladimir Neklyayev detained in Belarus - news agency directorWorld March 25, 5:33
Russia submits amicus curiae brief to US Supreme CourtRussian Politics & Diplomacy March 25, 3:34
Russia, China suggest for UN SC to adopt resolution on chemical terrorism threatRussian Politics & Diplomacy March 25, 3:23
Russian lawmaker compares European Union to Soviet UnionRussian Politics & Diplomacy March 25, 3:16
Russian emergencies ministry says fire at Kazan’s gunpowder factory fully extinguishedWorld March 25, 3:01
Relations btw US, Russia worst over half-century - Lukin quoting KissingerRussian Politics & Diplomacy March 25, 2:58
Russia suggests setting up international coalition for demining operations in SyriaRussian Politics & Diplomacy March 25, 1:08
One person dies in fire at gunpowder factory in Russia's KazanWorld March 24, 21:47
Russia's 'Gentlefan' baton passed on to Krasnodar ahead of Cote d’Ivoire friendlySport March 24, 21:34
MOSCOW, June 3. /TASS/. India’s Glenmark Pharmaceuticals Ltd is exploring an opportunity of localizing ready pharmaceutical drugs production in Russia, general director of Glenmark’s division in Russia Glenmark Impex Elena Astakhova said.
"We have such ideas and we are considering such an opportunity in principle. However, no final decision has been made yet," Astakhova said. She did not clarify the timeline and basic parameters of projects.
The company has no local production in Russia for the time being. The annual turnover of Glenmark in Russia is estimated at 2 bln rubles ($37.5 mln). Glenmark owns 14 ready drugs and substances factories in four countries and six research centers.